Cargando…
Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
BACKGROUND: Resistance to platinum-based chemotherapy is one of the crucial problems in ovarian cancer treatment. Ghrelin, a widely distributed peptide hormone, participates in a series of cancer progression. The aim of this study is to determine whether ghrelin influences the sensitivity of ovarian...
Autores principales: | Leng, Yun, Zhao, Can, Yan, Guoliang, Xu, Shuangyue, Yang, Yinggui, Gong, Ting, Li, Xin, Li, Chenglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597245/ https://www.ncbi.nlm.nih.gov/pubmed/34789301 http://dx.doi.org/10.1186/s13048-021-00907-9 |
Ejemplares similares
-
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the
ERK pathway
por: Bai, R.X., et al.
Publicado: (2016) -
Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro
por: Dong, Pei-Xin, et al.
Publicado: (2008) -
Invasiveness of mouse embryos to human ovarian cancer cells HO8910PM and the role of MMP-9
por: Ding, Xiaoyan, et al.
Publicado: (2012) -
Knockdown of Long Noncoding RNA NR_026689 Inhibits Proliferation and Invasion and Increases Apoptosis in Ovarian Carcinoma HO-8910PM Cells
por: Zhang, Xin, et al.
Publicado: (2017) -
Effect of 3`-Azido-3`-Deoxythymidine (AZT) on Telomerase Activity and Proliferation of HO-8910 Cell Line of Ovarian Cancer
por: Li, Hongmei, et al.
Publicado: (2006)